E. Hahn

发表

N-demethylation of morphine in rat brain is localised in sites with high opiate receptor content

J. Fishman, E. Hahn, B. Norton, 1976, Nature.

Nalmefene: radioimmunoassay for a new opioid antagonist.

R. Dixon, J. Hsiao, E. Hahn, 1984, Journal of pharmaceutical sciences.

Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists.

J. Fishman, E. Hahn, R. Heilman, 1975, Journal of medicinal chemistry.

Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintainance of body weight in rats

G. Pasternak, R. Bodnar, P. Mann, 1988, Neuropharmacology.

NALOXONE, A SPECIFIC OPIOID ANTAGONIST, REVERSES CHRONIC IDIOPATHIC CONSTIPATION

M. Kreek, J. Fishman, E. Hahn, 1983, The Lancet.

Opiate target site N-demethylase enzymes: differences from the liver N-demethylase.

J. Fishman, E. Hahn, B. Norton, 1979, Biochemical and biophysical research communications.

19-Hydroxylation and aromatization of androgens in the developing rat brain.

J. Fishman, E. Hahn, J. Michnovicz, 1987, Endocrinology.

The role of brain metabolism in the action of opiates

E. Hahn, 1985, Medicinal research reviews.

Testing and evaluation of opiate analgesics and antagonists.

E. Hahn, 1985, Methods and findings in experimental and clinical pharmacology.

Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.

G. Pasternak, R. Goodman, E. Hahn, 1985, The Journal of pharmacology and experimental therapeutics.

Early exposure to naloxone increases blood pressure in normotensive and hypertensive rats.

C. Martucci, S. Spector, J. Gilligan, 1982, Biochemical and biophysical research communications.

Brain opiate receptor concentrations are increased in adult spontaneously hypertensive rats.

C. Martucci, E. Hahn, 1979, Endocrine research communications.

Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites.

G. Pasternak, E. Hahn, 1982, Life sciences.

Irreversible opiate agonists and antagonists: the 14- hydroxydihydromorphinone azines

G. Pasternak, E. Hahn, M. Carroll-Buatti, 1982, Journal of Neuroscience.

Naloxone radioimmunoassay: an improved antiserum

M. Kreek, R. Lahita, C. Inturrisi, 1983, The Journal of pharmacy and pharmacology.

19-Hydroxylation of androgens in the rat brain.

J. Fishman, S. Miyairi, E. Hahn, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Catechol estrogen formation and metabolism in brain tissue: comparison of tritium release from different positions in ring A of the steroid.

J. Fishman, P. Jellinck, E. Hahn, 1984, Endocrinology.

Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine

G. Pasternak, R. Bodnar, P. Mann, 2004, Psychopharmacology.

Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.

G. Pasternak, E. Hahn, 1980, Journal of medicinal chemistry.

Narcotic antagonists. V. Stereochemistry of reactions at C-6 in 14-hydroxynoroxymorphone derivatives.

J. Fishman, E. Hahn, 1975, The Journal of organic chemistry.

Chronic naloxone increases opiate binding in SHR and WKY rats

E. Hahn, 1984, Neurochemical Research.

Unexpected effects of nalmefene, a new opiate antagonist, on the hypothalamic-pituitary-gonadal axis in the male rat

C. Bardin, P. Limonta, R. Thau, 1985, Steroids.

Influence of gender and castration on liver and CNS N-demethylation of morphine in rats1☆

J. Fishman, E. Hahn, B. Norton, 1977 .

Comparative in vivo distribution of opiate agonists and antagonists by means of double isotope techniques.

J. Fishman, E. Hahn, B. Norton, 1975, Life sciences.

Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone.

G. Pasternak, M. Luke, E. Hahn, 1988, Life sciences.

Changes in rat brain opiate receptor content upon castration and testosterone replacement.

J. Fishman, E. Hahn, 1979, Biochemical and biophysical research communications.

Naloxone benzoylhydrazone (NalBzoH) analgesia.

G. Pasternak, D. Howard, C. Pick, 1990, The Journal of pharmacology and experimental therapeutics.

Absence of reactive intermediates in the formation of catechol estrogens by rat liver microsomes.

J. Fishman, P. Jellinck, E. Hahn, 1986, The Journal of biological chemistry.

J. Fishman, E. Hahn, B. Norton, 1976, Research communications in chemical pathology and pharmacology.

Stereochemistry of 1,2-hydrogen loss during aromatization in the brain.

J. Fishman, E. Hahn, 1985, Journal of steroid biochemistry.

The nature of the final oxidative step in the aromatization sequence

J. Fishman, E. Hahn, 1987, Steroids.

Castration affects male rat brain opiate receptor content.

J. Fishman, E. Hahn, 1985, Neuroendocrinology.

Opiate regulation of estradiol-2-hydroxylase in brains of male rats: mechanism for control of pituitary hormone secretion.

J. Fishman, E. Hahn, B. Norton, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Preparation and evaluation of a sustained naloxone delivery system in rats.

J. Fishman, E. Hahn, B. Norton, 1975, Pharmacology.

Preparation of morphine-6-3H and its isotopic stability in man and in rat.

J. Fishman, M. Cotter, E. Hahn, 1974, Journal of medicinal chemistry.

PREPARATION OF MORPHINE-6-(3)H AND ITS ISOTOPIC STABILITY IN MAN AND IN RAT

J. Fishman, M. Cotter, E. Hahn, 1974 .

Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.

G. Pasternak, D. Paul, E. Hahn, 1989, The Journal of pharmacology and experimental therapeutics.

Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.

G. Pasternak, S. Galetta, E. Hahn, 1987, Life sciences.

Immunological probe of estrogen biosynthesis. Evidence for the 2 beta-hydroxylative pathway in aromatization of androgens.

J. Fishman, E. Hahn, 1984, The Journal of biological chemistry.